# Adipose tissue IL-23 is associated with fasting blood glucose and HbA1c in overweight/obese individuals

## TL;DR

Adipose tissue IL-23 is linked to higher blood sugar and insulin resistance in overweight/obese individuals.

## Contribution

This study identifies a novel association between adipose tissue IL-23 and glycemic markers in obesity.

## Key findings

- Adipose tissue IL-23 correlates positively with fasting blood glucose and HbA1c in obese individuals.
- IL-23 is linked to other inflammatory markers and inversely related to adiponectin in adipose tissue.
- The findings suggest a role for IL-23 in metabolic inflammation and insulin resistance in obesity.

## Abstract

IL-23, a proinflammatory cytokine, plays a role in the development of inflammatory diseases. However, the association between IL-23 expression in adipose tissue (AT) and glycemic changes in obesity remains unclear. This cross-sectional study aimed to examine the relationship of adipose tissue IL-23 (AT-IL-23) expression with other inflammatory mediators within the same compartment and insulin resistance markers fasting blood glucose (FBG) and glycated hemoglobin (HbA1c) in overweight/obese individuals. Fat biopsies were collected from 10 individuals with a body mass index (BMI) < 25kg/m2 and 51 individuals with a BMI > 25kg/m2 and were analyzed for IL-23 and other inflammatory markers using qRT-PCR. Inflammatory markers, including CD16, CD11c, CCR2, CCR5, TNF-α, IL-1β, IL-2, IL-12, CCL8, CCL19, and CXCL9, were positively correlated with IL-23 in the AT-compartment in the obesity context. Notably, AT-IL-23 was correlated positively with FBG, HbA1c, and homeostasis model assessment of insulin resistance (HOMA-IR), while negatively correlating with adiponectin. These findings suggest that AT-IL-23 is associated with metabolic inflammation and insulin resistance in obesity, suggesting it may be of interest for future biomarker studies.